• FirefoxInstall the new Firefox »
  •  Dow Up 0.08% Nasdaq Up 0.23%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.58 Up 0.00(0.05%) 9:31AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.58
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:3.50
    Beta:0.57
    Next Earnings Date: 9-Mar-15IMUC Earnings announcement
    Day's Range:0.58 - 0.59
    52wk Range:0.53 - 1.46
    Volume:2,100
    Avg Vol (3m):521,247
    Market Cap:36.39M
    P/E (ttm):N/A
    EPS (ttm):-0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCUp 0.05%36.39M
    AGENUp 0.79%321.57M
    DNDNDown 13.61%N/A
    STMLUp 1.00%210.07M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.17
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback